| 000 | 01812 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515224941.0 | ||
| 264 | 0 | _c20100914 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1816-5370 | ||
| 024 | 7 |
_a10.1177/0218492310368732 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, Chi-Hang | |
| 245 | 0 | 0 |
_aProcedure-related myonecrosis after bare and drug-eluting stent implantation. _h[electronic resource] |
| 260 |
_bAsian cardiovascular & thoracic annals _cJun 2010 |
||
| 300 |
_a272-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngioplasty, Balloon, Coronary _xadverse effects |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCardiovascular Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCreatine Kinase, MB Form _xblood |
| 650 | 0 | 4 | _aDrug-Eluting Stents |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetals |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xenzymology |
| 650 | 0 | 4 |
_aMyocardium _xenzymology |
| 650 | 0 | 4 | _aNecrosis |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aProsthesis Design |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSingapore |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 | _aStents |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aTse, Hung-Fat | |
| 700 | 1 | _aTai, Bee-Choo | |
| 700 | 1 | _aChen, Zhaojin | |
| 700 | 1 | _aChan, Mark Y | |
| 700 | 1 | _aTan, Huay-Cheem | |
| 773 | 0 |
_tAsian cardiovascular & thoracic annals _gvol. 18 _gno. 3 _gp. 272-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0218492310368732 _zAvailable from publisher's website |
| 999 |
_c19870541 _d19870541 |
||